Cubist Pharmaceuticals, Inc. (CBST)

[Telephonics]

I expect there will be little or no news to report while the FDA and CBST work out the details of the labeling to be used on Dapto.As a result the share price should drift-perhaps a bit lower than current price. It is possible,however that due to the unanimous vote of the panel to expand the indications for use that Doctors will increase the use of Dapto in "off label" applications. This could well affect the bottom line and the next financial quarterly report could well hold a pleasant surprise.